Showing results (1-10 of 526) with videos related to
Sort By:
Pageof 53
Medical Oncology (Northwood, London, England)|August 16, 2002
Future prospects for alemtuzumab (MabCampath)Kanti Rai, Michael HallekLeukemia & Lymphoma|April 27, 2013
Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemiaJacqueline Barrientos, Kanti RaiLeukemia & Lymphoma|May 24, 2011
Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current usesThomas M Habermann, Kanti RaiBest Practice & Research. Clinical Haematology|July 13, 2010
Therapy of chronic lymphocytic leukaemiaMichael HallekHematology. American Society of Hematology. Education Program|November 24, 2005
Chronic lymphocytic leukemia (CLL): first-line treatmentMichael Hallek, Hematology. American Society of Hematology. Education Program|December 10, 2013
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategiesMichael HallekHematology. American Society of Hematology. Education Program|December 17, 2009
State-of-the-art treatment of chronic lymphocytic leukemiaMichael HallekHematology. American Society of Hematology. Education Program|December 4, 2018
On the architecture of translational research designed to control chronic lymphocytic leukemiaMichael HallekBlood|September 26, 2013
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategiesMichael HallekAmerican Journal of Hematology|August 8, 2017
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatmentMichael HallekPageof 53